TWI844535B - 短雙歧桿菌ｍｃｃ１２７４之用途、篩選具有抗肥胖作用之雙歧桿菌屬細菌之方法以及篩選對具有抗肥胖作用之雙歧桿菌屬細菌之應答者之方法 - Google Patents

短雙歧桿菌ｍｃｃ１２７４之用途、篩選具有抗肥胖作用之雙歧桿菌屬細菌之方法以及篩選對具有抗肥胖作用之雙歧桿菌屬細菌之應答者之方法 Download PDF

Info

Publication number
TWI844535B
TWI844535B TW108111102A TW108111102A TWI844535B TW I844535 B TWI844535 B TW I844535B TW 108111102 A TW108111102 A TW 108111102A TW 108111102 A TW108111102 A TW 108111102A TW I844535 B TWI844535 B TW I844535B
Authority
TW
Taiwan
Prior art keywords
bifidobacterium
bacteria
group
ferm
bifidobacterium breve
Prior art date
Application number
TW108111102A
Other languages
English (en)
Chinese (zh)
Other versions
TW201944906A (zh
Inventor
南淳一
宣旭
Original Assignee
日商森永乳業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商森永乳業股份有限公司 filed Critical 日商森永乳業股份有限公司
Publication of TW201944906A publication Critical patent/TW201944906A/zh
Application granted granted Critical
Publication of TWI844535B publication Critical patent/TWI844535B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Polymers & Plastics (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
TW108111102A 2018-03-29 2019-03-29 短雙歧桿菌ｍｃｃ１２７４之用途、篩選具有抗肥胖作用之雙歧桿菌屬細菌之方法以及篩選對具有抗肥胖作用之雙歧桿菌屬細菌之應答者之方法 TWI844535B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018-064982 2018-03-29
JP2018064982 2018-03-29

Publications (2)

Publication Number Publication Date
TW201944906A TW201944906A (zh) 2019-12-01
TWI844535B true TWI844535B (zh) 2024-06-11

Family

ID=68059033

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108111102A TWI844535B (zh) 2018-03-29 2019-03-29 短雙歧桿菌ｍｃｃ１２７４之用途、篩選具有抗肥胖作用之雙歧桿菌屬細菌之方法以及篩選對具有抗肥胖作用之雙歧桿菌屬細菌之應答者之方法

Country Status (4)

Country Link
US (1) US12059442B2 (https=)
JP (2) JP7408539B2 (https=)
TW (1) TWI844535B (https=)
WO (1) WO2019189408A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7556881B2 (ja) * 2019-04-17 2024-09-26 バイオガイア エイビー プロバイオティック細菌の治療用マイクロベシクル
WO2021107500A1 (ko) 2019-11-29 2021-06-03 주식회사 지니스 혈중 암모니아 수치 저하능을 갖는 균주 및 이를 포함하는 신경세포 보호용 조성물
US20210237064A1 (en) * 2020-01-31 2021-08-05 Astrin Biosciences, Inc. Biological Fluid Filtration System
CA3205469A1 (en) * 2020-12-18 2022-06-23 The General Hospital Corporation Probiotics compositions and method of using the same to enhance growth and social function in children
JP7113550B1 (ja) * 2021-05-11 2022-08-05 株式会社アルソア慧央グループ 抗鬱剤、抗老化剤及び抗肥満剤
JP7549407B2 (ja) * 2021-12-23 2024-09-11 株式会社メタジェン 情報提供システム
CN115300605A (zh) * 2022-08-16 2022-11-08 比菲德(北京)生物科技有限公司 一种用于抗肥胖、瘦身的益生菌粉及其应用
EP4673156A1 (en) * 2023-02-28 2026-01-07 University Of South Florida Method of making a probiotic fermented product
IT202300021603A1 (it) * 2023-10-17 2025-04-17 Noos S R L Nuova composizione a base di probiotici

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102970997A (zh) * 2009-09-17 2013-03-13 森永乳业株式会社 抗肥胖剂、抗肥胖用饮食品、糖耐量改善剂和糖耐量改善用饮食品
CN107684567A (zh) * 2017-11-07 2018-02-13 大连医科大学 一种用于改善肥胖和降低血脂的复合益生菌制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010285425A (ja) 2009-05-12 2010-12-24 Fujifilm Corp 腸内細菌叢構成比率調整剤
JP7244977B2 (ja) * 2016-03-11 2023-03-23 シオノギヘルスケア株式会社 腸内細菌叢調整用組成物
AU2017318650B2 (en) * 2016-09-02 2021-12-09 Société des Produits Nestlé S.A. Compositions and methods for modulating gastrointestinal microflora in a canine
CN107125767B (zh) * 2017-04-28 2020-09-29 黑龙江大学 一种短双歧杆菌、发酵乳杆菌和植物乳杆菌三菌复合微粒子的制备方法及应用
CN107760620B (zh) 2017-10-18 2021-05-04 天津科睿恒生物科技有限公司 一株改善易胖体质及子代体重的植物乳杆菌及应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102970997A (zh) * 2009-09-17 2013-03-13 森永乳业株式会社 抗肥胖剂、抗肥胖用饮食品、糖耐量改善剂和糖耐量改善用饮食品
CN107684567A (zh) * 2017-11-07 2018-02-13 大连医科大学 一种用于改善肥胖和降低血脂的复合益生菌制剂

Also Published As

Publication number Publication date
JP2024026410A (ja) 2024-02-28
US12059442B2 (en) 2024-08-13
TW201944906A (zh) 2019-12-01
US20210196767A1 (en) 2021-07-01
WO2019189408A1 (ja) 2019-10-03
JP7408539B2 (ja) 2024-01-05
JPWO2019189408A1 (ja) 2021-03-18

Similar Documents

Publication Publication Date Title
TWI844535B (zh) 短雙歧桿菌ｍｃｃ１２７４之用途、篩選具有抗肥胖作用之雙歧桿菌屬細菌之方法以及篩選對具有抗肥胖作用之雙歧桿菌屬細菌之應答者之方法
JP7280243B2 (ja) 栄養組成物並びに該栄養組成物を用いた飲食品組成物及び調製粉乳
JP7280069B2 (ja) 機能性消化管障害予防又は改善用組成物、並びに、該機能性消化管障害予防又は改善用組成物を用いた医薬品組成物及び飲食品組成物
JPWO2019117212A1 (ja) ビフィドバクテリウム属細菌を有効成分とする組成物
WO2017000249A1 (en) Bifidobacteria as probiotic foundation species of gut microbiota
JP2019116423A (ja) 整腸用組成物
JPWO2019188943A1 (ja) 脳血流低下の予防及び／又は改善用組成物
Ansari et al. Probiotic lactic acid bacteria: Taxonomy, properties and benefits
JP7572789B2 (ja) 腸内細菌叢改善用組成物
WO2024101341A1 (ja) 新生児又は乳幼児のための組成物
JP7368484B2 (ja) 組成物並びに該組成物含有する飲食品組成物および調製乳
JP7299744B2 (ja) 血中尿酸値低減用組成物、及び高尿酸血症予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
WO2019180965A1 (ja) 学童期以降の高血糖に起因する疾患の予防のための乳幼児用組成物
Pirouzian et al. Probiotic Lactic Acid Bacteria 46
JP7333732B2 (ja) 筋肉量及び／又は筋力の維持、或いは筋肉量及び／又は筋力の低下抑制用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
JP7766703B2 (ja) トレオン酸含有組成物及びその製造方法
JP7591364B2 (ja) 健康寿命延長用組成物
JP7326075B2 (ja) 腎機能障害の予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
WO2020251044A1 (ja) ビフィドバクテリウム属細菌を有効成分とする組成物
JP2021127321A (ja) 持久力向上用組成物
JP7696423B2 (ja) 組成物
JP7309436B2 (ja) 腎機能障害予防又は改善用組成物、並びに、該腎機能障害予防又は改善用組成物を用いた医薬品組成物及び飲食品組成物
WO2025005237A1 (ja) 腸内菌叢でのＦｕｓｏｂａｃｔｅｒｉｕｍ属菌の制御用組成物及びその利用
JP2026011440A (ja) 労働パフォーマンスの向上用組成物
JP2021042143A (ja) 脂質代謝異常及び／又は糖代謝異常の予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees